Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) is a late-stage biopharmaceutical company focused on discovering, developing, and seeking to commercialize innovative therapies for diseases with significant unmet medical needs. The company’s development programs are centered on advancing treatments designed to address serious neuropsychiatric, inflammatory, and cardiometabolic conditions.

Topics discussed include the company’s clinical development programs, business strategy, growth initiatives, market opportunities, and long-term outlook.

This company webcast was recorded during the Lytham Partners Spring 2026 Investor Conference.